|Articles|July 1, 2002
Eye drops delay onset of glaucoma
Author(s)Lynda Charters
Bethesda, MD-Glaucoma management has entered a new era. Based on the results of the long-awaited Ocular Hypertension Treatment Study (OHTS), physicians now have clear guidelines for treating patients at high risk for developing glaucoma that may actually prevent the disease.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
 













































.png)


